Magnesium sulphate in the management of patients with aneurysmal subarachnoid haemorrhage: A meta-analysis of prospective controlled trials

Brain Injury

Volumn 24, Issue 5, 2010, Pages 730-735

  Ma, Li ^a   Liu, Wei Guo ^a   Zhang, Jian Min ^a   Chen, Gao ^a   Fan, Jing ^a   Sheng, Han Song ^a  

^a ZHEJIANG UNIVERSITY   (China)

Author keywords

Aneurysm; Calcium antagonist; Delayed cerebral ischemia; Magnesium; Subarachnoid haemorrhage

Indexed keywords

MAGNESIUM SULFATE; NIMODIPINE; PLACEBO;

ARTICLE; BRAIN ARTERY ANEURYSM; BRAIN ISCHEMIA; CLINICAL TRIAL; CONTINUOUS INFUSION; DRUG BLOOD LEVEL; DRUG EFFICACY; DRUG MONITORING; DRUG SAFETY; HEART ARRHYTHMIA; HEART INFARCTION; HUMAN; HYPERMAGNESEMIA; HYPOTENSION; KIDNEY FAILURE; LOADING DRUG DOSE; META ANALYSIS; PHLEBITIS; RESPIRATORY ARREST; RISK FACTOR; SENSITIVITY ANALYSIS; SUBARACHNOID HEMORRHAGE; SYSTEMATIC REVIEW; TREATMENT OUTCOME;

EID: 77950549453     PISSN: 02699052     EISSN: 1362301X     Source Type: Journal    
DOI: 10.3109/02699051003610516     Document Type: Article

References (25)

1. Rinkel GJ. Medical management of patients with aneurysmal subarachnoid haemorrhage. International Journal of Stroke 2008;3:193-204.
2. Huang J, van Gelder JM. The probability of sudden death from rupture of intracranial aneurysms: A meta-analysis. Neurosurgery 2002;51:1101-1105.
3. Wong GK, Chan MT, Poon WS, Boet R, Gin T. Magnesium therapy within 48 hours of an aneurysmal subarachnoid haemorrhage: Neuro-panacea. Neurological Research 2006; 28:431-435. (Pubitemid 43967790)
4. Keyrouz SG, Diringer MN. Clinical review: Prevention and therapy of vasospasm in subarachnoid haemorrhage. Critical Care 2007;4:211-220.
5. Bederson JB, Connolly Jr ES, Batjer HH, Dacey RG, Dion JE, Diringer MN, Duldner Jr JE, Harbaugh RE, Patel AB, Rosenwasser RH. Guidelines for the management of aneurysmal subarachnoid hemorrhage: A statement for healthcare professionals from a special writing group of the Stroke Council, American Heart Association. Stroke 2009; 40:994-1025.
6. Schmid-Elsaesser R, Kunz M, Zausinger S, Prueckner S, Briegel J, Steiger HJ. Intravenous magnesium versus nimodipine in the treatment of patients with aneurysmal subarachnoid haemorrhage: A randomized study. Neurosurgery 2006;58:1054-1065.
7. Stippler M, Crago E, Levy EI, Kerr ME, Yonas H, Horowitz MB, Kassam A. Magnesium infusion for vasospasm prophylaxis after subarachnoid haemorrhage. Journal of Neurosurgery 2006;105:723-729.
8. Veyna RS, Seyfried D, Burke DG, Zimmerman C, Mlynarek M, Nichols V, Marrocco A, Thomas AJ, Mitsias PD, Malik GM. Magnesium sulfate therapy after aneurysmal subarachnoid haemorrhage. Journal of Neurosurgery 2002;96:510-514.
9. Manno EM. Magnesium sulphate and cerebral vasospasm. Lancet Neurology 2005;4:329-330.
10. Belfort MA, Anthony J, Saade GR, Allen Jr JC. A comparison of magnesium sulfate and nimodipine for the prevention of eclampsia. New England Journal of Medicine 2003;348: 304-311.
11. van den Bergh WM, Algra A, van Kooten F, Dirven CM, van Gijn J, Vermeulen M, Rinkel GJ. Magnesium sulfate in aneurysmal subarachnoid haemorrhage: A randomized controlled trial. Stroke 2005;36:1011-1015.
12. Boet R, Mee E. Magnesium sulfate in the management of patients with fisher grade 3 subarachnoid haemorrhage: A pilot study. Neurosurgery 2000;47:602-606.
13. Dorhout Mees SM, Rinkel GJ, Feigin VL, Algra A, van den Bergh WM, Vermeulen M, van Gijn J. Calcium antagonists for aneurysmal subarachnoid haemorrhage. Cochrane Database of Systematic Reviews 2007;18:CD000277.
14. Jadad AR, Moore RA, Carroll D, Jenkinson C, Reynolds DJ, Gavaghan DJ, McQuay HJ. Assessing the quality of reports of randomized clinical trials: Is blinding necessary? Controlled Clinical Trials 1996;17:1-12.
15. Prevedello DM, Cordeiro JG, de Morais AL, Saucedo Jr NS, Chen IB, Araujo JC. Magnesium sulfate: Role as possible attenuating factor in vasospasm morbidity. Surgical Neurology 2006;65(Suppl 1):S1:14-S1:20.
16. van Norden AG, van den Bergh WM, Rinkel GJ. Dose evaluation for long-term magnesium treatment in aneurysmal subarachnoid haemorrhage. Journal of Clinical Pharmacy and Therapeutics 2005;30:439-442.
17. Wong GK, Chan MT, Boet R, Poon WS, Gin T. Intravenous magnesium sulfate after aneurysmal subarachnoid haemorrhage: A prospective randomized pilot study. Journal of Neurosurgical Anesthesiology 2006;18:142-148.
18. Muroi C, Terzic A, Fortunati M, Yonekawa Y, Keller E. Magnesium sulfate in the management of patients with aneurysmal subarachnoid haemorrhage: A randomized, placebo-controlled, dose-adapted trial. Surgical Neurology 2008;69:33-39.
19. Macdonald RL, Curry DJ, Aihara Y, Zhang ZD, Jahromi BS, Yassari R. Magnesium and experimental vasospasm. Journal of Neurosurgery 2004;100:106-110.
20. Chia RY, Hughes RS, Morgan MK. Magnesium: A useful adjunct in the prevention of cerebral vasospasm following aneurysmal subarachnoid haemorrhage. Journal of Clinical Neuroscience 2002;9:279-281.
21. Van de Water JM, Van den Bergh WM, Hoff RG, Algra A, Rinkel GJ. Hypocalcaemia may reduce the beneficial effect of magnesium treatment in aneurysmal subarachnoid haemorrhage. Magnesium Research 2007;20:130-135. (Pubitemid 47084040)
22. Wong GK, Poon WS. Magnsium and vasospasm. Journal of Neurosurgery 2007;106:938-939.
23. Wong GK, Boet R, Poon WS, Chan MT. Trial design in 'Magnesium sulphate in aneurysmal subarachnoid haemorrhage: A randomized controlled trial'. Stroke 2005;36: 2530-2531.
24. Dorhout Mees SM. Magnesium in aneurysmal subarachnoid haemorrhage (mash ii) phase iii clinical trial mash-ii study group. International Journal of Stroke 2008;3:63-65.
25. Wong GK, Poon WW. Re: Magnesium sulfate: Role as possible attenuating factor in vasospasm morbidity. Surgical Neurology 2006;66:110-111.